Pricing Log in Create free account
Friday 6 November 2026 Export NEOG’s income statement to Excel — free account

Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.72 0.04 +0.34%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Neogen Corporation (NEOG) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Neogen Corporation (NEOG) trades at a EV/EBITDA of 27.2×. Over the past ten years it has ranged from 10.7× (April 2025) to 76.6× (January 2023); the current reading is higher than 31% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2026 25.1× 71.49%
FY2025 14.6× (24.58%)
FY2024 19.4× (35.72%)
FY2023 30.2× 1.18%
FY2022 29.8× (36.56%)
FY2021 47.0× 17.74%
FY2020 40.0× 28.89%
FY2019 31.0× (26.47%)
FY2018 42.2× 48.86%
FY2017 28.3× 11.63%

Quarterly newest first

Period EV/EBITDA Change
Aug 2026 27.0× 7.48%
May 2026 25.1× (28.74%)
Feb 2026 35.2× 78.57%
Nov 2025 19.7× 23.23%
43 more quarters

Against its own ten years

Low 10.7× High 76.6×
Ten-year median 31.0×
Current reading's percentile 31

EV/EBITDA against peers

Company EV/EBITDA
BFLY Butterfly Network, Inc. compare n/m
ESTA Establishment Labs Holdings Inc. compare n/m
AXGN AxoGen, Inc. compare n/m
ALMR Alamar Biosciences, Inc. compare n/m
ITGR Integer Holdings Corporation compare 18.8×
UFPT UFP Technologies, Inc. compare 20.5×
TMDX TransMedics Group, Inc. compare 22.0×
NEOG Neogen Corporation 27.2×
INSP Inspire Medical Systems, Inc. compare 48.4×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on NEOG